#AANAM – Genetic Testing Recommended for All ALS Patients
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22.
Articles by Marta Figueiredo, PhD
#AANAM – Better REFALS Trial Response Seen in ALS Patient Group
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22.
#AANAM – Unique Immune Profile Identified for Fast-progressing ALS
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22.
#AANAM – C9orf72 Mutations Linked to Early, Worse Cognitive Deficits
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April…
Maze Therapeutics Advances Potential Gene Therapy Involving ATXN2
Maze Therapeutics is advancing the development of a lead gene therapy candidate for amyotrophic lateral sclerosis (ALS), which works…
ALS-linked Mutations Surprisingly Common in Absence of Family History
A higher than expected proportion of amyotrophic lateral sclerosis (ALS) patients — most without a family history of ALS…
Biogen Declines Early Access to Tofersen Until Pivotal Trial Ends
Biogen will not offer early access to tofersen, its experimental therapy for familial amyotrophic lateral sclerosis (ALS)…
‘End ALS Challenge’ Invites AI Community to Tackle 3 Key Questions
Roche Canada’s Artificial Intelligence Centre of Excellence (AI CoE), in collaboration with Answer ALS and EverythingALS, opened a…
Phase 3 Trial of Stem Cell Therapy NeuroNata-R Enrolling in Korea
Note: This story was updated March 31, 2021, to note that the ALSummit trial has been approved by the…
#MDA2021 – Early Use of Radicava Seen to Lower Cumulative Risk of ALS Progression
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 MDA Virtual Clinical and Scientific Conference,…